BioNTech
A Scientific Communications Leader is a strategic leadership role responsible for defining and driving the integrated scientific communications strategy for oncology assets, ensuring the development of a clear, differentiated, evidence-based scientific narrative that supports Medical Affairs objectives and cross-functional alignment.
Headquarters
Mainz, Rhineland-Palatinate, Germany
Company Size
1001-5000 employees
Founded
2008
BioNTech is a biotechnology company that develops mRNA-based cancer immunotherapies, next-generation immunomodulators and targeted oncology therapies, and vaccines against infectious diseases. It combines proprietary mRNA, cell- and gene-based platforms to design both individualized and off-the-shelf treatments and advance programs through preclinical and clinical development. The company gained global prominence through its collaboration with Pfizer on an mRNA COVID-19 vaccine and pursues broad partnerships and scaled manufacturing to bring therapies to patients worldwide. BioNTech emphasizes translational science and personalized medicine to transform outcomes in oncology and infectious disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for BioNTech.
31% above the average for this role
Scientific Director, Medical Information & Medical Communications
Tango Therapeutics
Global Medical Affairs Leader – Emerging Portfolio Strategy
AstraZeneca
Associate Director, Scientific Communications ( Oncology)
Regeneron Pharmaceuticals
Associate Director, Scientific Communications
Compass Pathways
Senior Director, Medical Affairs
LeonaBio
Senior Manager/Associate Director, Scientific Communications & Publications
Kura Oncology